Long-term follow-up of upper and lower extremity vasculitis related to giant cell arteritis: A series of 36 patients

Medicine

Volumn 90, Issue 1, 2011, Pages 40-51

  Assie, Cyrielle ^a   Janvresse, Alain ^a   Plissonnier, Didier ^a   Levesque, Hervé ^a   Marie, Isabelle ^a  

^a ROUEN UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; AZATHIOPRINE; CYCLOPHOSPHAMIDE; ILOPROST; IMMUNOSUPPRESSIVE AGENT; LOW MOLECULAR WEIGHT HEPARIN; METHOTREXATE; PREDNISONE; STEROID;

ADULT; AGED; AMPUTATION; ANGIOPLASTY; AORTA; AORTA ANEURYSM; AORTA DISEASE; ARM; ARTERY RUPTURE; ARTICLE; AXILLARY ARTERY; BLOOD VESSEL GRAFT; BRACHIAL ARTERY; CLINICAL ARTICLE; CLINICAL EXAMINATION; CLINICAL FEATURE; DEEP FEMORAL ARTERY; DETERIORATION; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG WITHDRAWAL; EMERGENCY TREATMENT; ENDARTERECTOMY; FEMALE; FEMORAL ARTERY; FOLLOW UP; GIANT CELL; GIANT CELL ARTERITIS; HUMAN; INTERNAL ILIAC ARTERY; INTERNAL MEDICINE; ISCHEMIA; LEG; LIFE; LIMB; LONG TERM CARE; MALE; MEDICAL RECORD REVIEW; OBSERVATION; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STEROID THERAPY; SUBCLAVIAN ARTERY; SUPERFICIAL FEMORAL ARTERY; SYMPTOM; THROMBECTOMY; TIBIAL ARTERY; UNIVERSITY; VASCULITIS; VEIN BYPASS; VEIN GRAFT; VESSEL;

AGED; AGED, 80 AND OVER; CHI-SQUARE DISTRIBUTION; DIAGNOSTIC IMAGING; FEMALE; FOLLOW-UP STUDIES; FRANCE; GIANT CELL ARTERITIS; HUMANS; LOWER EXTREMITY; MALE; MIDDLE AGED; PREVALENCE; RETROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME; UPPER EXTREMITY; VASCULITIS;

EID: 78651260234     PISSN: 00257974     EISSN: None     Source Type: Journal    
DOI: 10.1097/MD.0b013e318206af16     Document Type: Article

References (117)

1. Akdal G, Thurtell MJ, Halmagyi GM. Giant cell arteritis presenting with bilateral vertebral and axillary artery occlusions. Intern Med J. 2008;38:741-742.
2. Amann-Vesti BR, Koppensteiner R, Rainoni L, Pfamatter T, SchneiDer E. Immediate and long-term outcome of upper extremity balloon angioplasty in giant cell arteritis. J Endovasc Ther. 2003;10:371-375.
3. Amatucci G, Del Mastro G, Iandoli R. Horton giant cell arteritis of the legs. J Cardiovasc Surg. 1997;38:309-312.
4. Atlas LN. A case of Buergers disease in an old woman. Am Heart J. 1943;26:120-123.
5. Barrier J, Potel G, Rojouan J, Raffi F, Verlingue C, Renaut-Hovasse H, Peltier P, Planchon B, Grolleau JY. Stenose des gros troncs arteriels survenant au cours dune corticotherapie efficace de la maladie de Horton. Quatre cas. J Mal Vasc. 1983;8:189-197.
6. Bastin R, Godeau P, Lavernhe J, Leger L, Lemaigre G. Pseudo-polyarthrite rhizomelique de larterite temporale a larterite des membres inferieurs. Presse Med. 1969;77: 1649-1651.
7. Bengtsson BA, Malmvall BE. Prognosis of giant cell arteritis including temporal arteritis and polymyalgia rheumatica. A follow-up study on ninety patients treated with corticosteroids. Acta Med Scand. 1981;209:337-345
8. Benjilali L, Tazi Mezalek Z, Raffali J, El Imadi H, Harmouche H, Adnaoui M, Bensaid Y, Aouni M, Maaouni A. Atteinte des arteres des membres et maladie de Horton: a propos de cinq cas. Rev Med Interne. 2009;30:1004-1010.
9. Bleeker-Rovers CP, Bredie SJH, Van Der Meer JWM, Corstens FHM, Oyen WJG. Fluorine 18 fluorodeoxyglucose positron emission tomography in the diagnosis and follow-up of three patients with vasculitis. Am J Med. 2004;116:50-53.
10. Bley TA, Markl M, Schelp M, Uhl M, Frydrychowicz A, Vaith P, Peter HH, Langer M, Warnatz K. Mural inflammatory hyperenhancement in MRI of giant cell (temporal) arteritis resolves unDer corticosteroid treatment. Rheumatology. 2008;47: 65-67.
11. Bley TA, Uhl M, Carew J, Markl M, Schmidt D, Peter HH, Langer M, Wieben O. Diagnostic value of high-resolution MR imaging in giant cell arteritis. Am J Neuroradiol. 2007;28:1722-1727.
12. Bley TA, Warnatz K, Wieben O, Uhl M, Scholz C, Vaith P, Peter HH, Langer M. High resolution MRI in giant cell arteritis with mutiple inflammatory stenoses in both calves. Rheumatology. 2005;44:954-955.
13. 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a prospective study of 35 patients. Arthritis Rheum. 2006;55:131-137.
14. Blockmans D, Maes A, Stroobants S, Nuyts J, Bormans G, Knockaert D, Bobbaers H, Mortelmans L. New arguments for a vasculitic nature of polymyalgia rheumatica using positron emission tomography. Rheumatology. 1999;38:444-447.
15. Both M, Aries PM, Muller-Hulsbeck S, Jahnke T, Schafer PJ, Gross WL, Heller M, Reuter M. Balloon angioplasty of arteries of the upper extremities in patients with extracranial giant-cell arteritis. Ann Rheum Dis. 2006;65:1124-1130.
16. Brack A, Martinez-Taboada A, Stanson A, Goronzy JJ, Weyand CM. Disease pattern in cranial and large-vessel giant cell arteritis. Arthritis Rheum. 1999;42:311-317.
17. Bruk MI. Articular and vascular manifestations of polymyalgia rheumatica. Ann Rheum Dis. 1967;26:104-113.
18. Buono LM, De Virgiliis M, Foroozan R. Heparin therapy in giant cell arteritis. Br J Ophthalmol. 2004;88:298-301.
19. Cabanel G, Voog R, Phelip X, Verdier JM. Les atteintes arterielles de la maladie de Horton. Sem Hop Paris. 1969;45: 436-443.
20. Cailleux N, Levesque H, Borg JY, Clavier E, Courtois H. Maladie de Horton avec atteinte des troncs arteriels des membres superieurs. Role pathogene des anticorps anticardiolipine? A propos de deux observations. J Mal Vasc. 1992;17:157-159.
21. Caramaschi P, Biasi D, Carletto A, Zeminian S, Manzo T, Bambara LM. Large artery giant cell arteritis: a diagnosis to remember. Clin Rheumatol. 1997;16:636-637.
22. Cardell BS, Hanley T. A fatal case of giant-cell or temporal arteritis. J Pathol Bacteriol. 1951;63:587-597.
23. Chatelain D, Duhaut P, Schmidt J, Loire R, Bosshard S, Guernou M, Pellet H, Piette JC, Sevestre H, Ducroix JP; Groupe de Recherche sur l-Arterite a Cellules Geantes. Pathological features of temporal arteries in patients with giant cell arteritis presenting with permanent visual loss. Ann Rheum Dis. 2009;68:84-88.
24. Cohen HE, Shankar PJ, Martin JC, Lewis MH. Atypical giant cell arteritis resulting in arm amputation. Ann R Coll Surg Engl. 2003;85:260-262.
25. Dellapira PF, Eisenhauer AC. Bilateral percutaneous balloon angioplasty of the axillary arteries in a patient with giant cell arteritis and upper ischemic symptoms not responsive to corticosteroids. J Rheumatol. 1998;25:1429-1433.
26. De Bruyne L, Pauwels W, Raat F, Mast A. Giant cell (temporal) arteritis diagnosed following upper limb claudication. Acta Clin Belg. 2001;56:370-372.
27. De Gennes C, Le Thi Huong D, Wechsler B, Bercy J, Foncin JF, Piette JC, Godeau P. Temporal arteritis revealed by upper limb gangrene. J Rheumatol. 1989;16:130-132.
28. Di Giacomo V, Fraioli A, Carmenini G, Schietroma M, Meloni F, Grossi F. Polymyalgia rheumatica and systemic giant cell arteritis. Bioptic findings of the subclavian arteries in a case of aortic arch syndrome. Angiology. 1984;35:528-533.
29. Dupuy R, Mercie P, Neau D, Longy-Boursier M, Conri C. Giant cell arteritis involving the lower limbs. Rev Rhum Engl Ed. 1997;64:500-503.
30. Espinoza LR, Jara LJ, Silveira LH, Martinez-Osuna P, Zwolinska JB, Kneer C, Aguilar JL. Anticardiolipin antibodies in polymyalgia rheumatica-giant cell arteritis: association with severe vascular complications. Am J Med. 1991;90:474-478.
31. Ferrandiz D, Joguet R, Yvin JL. Ischemie subaigue du membre superieur survenant a la phase initiale du traitement corticoide dune maladie de Horton. Rev Med Interne. 1999;20:87-88.
32. Finlayson R, Robinson JO. Giant-cell arteritis of the legs. Br Med J. 1955;2:1595-1597.
33. Frangenheim H. Zur frage Der reisen-zellarteritis. Zentralb Allg Pathol. 1951;88:81-90.
34. Garcia-Porrua C, Pego-Reigosa R, Pifleiro A, Armesto V, Gonzalez-Gay M. Supraclavicular pulsatile mass as presenting sign of brachiocephalic trunk aneurysm in the long-term follow-up of giant cell arteritis. Arthritis Rheum. 2005;53:475-476.
35. Garcia Vazquez JM, Carreira JM, Seoane C, Vidal JJ. Superior and inferior limb ischaemia in giant cell arteritis: angiography follow-up. Clin Rheumatol. 1999;18:61-65.
36. Gonzalez-Gay MA. The diagnosis and management of patients with giant cell arteritis. J Rheumatol. 2005;32:1186-1188.
37. Gonzalez-Gay MA, Barros S, Lopez-Diaz MJ, Garcia-Porrua C, Sanchez-Andrade A, Llorca J. Giant cell arteritis: disease patterns of clinical presentation in a series of 240 patients. Medicine (Baltimore). 2005;84:269-276.
38. Gonzalez-Gay MA, Piñeiro A, Gomez-Gigirey A, Garcia-Porrua C, Pego-Reigosa R, Dierssen-Sotos T, Llorca J. Influence of traditional risk factors of atherosclerosis in the development of severe ischemic complications in giant cell arteritis. Medicine (Baltimore). 2004;83:342-347
39. Greene GM, Lain D, Sherwin RM, Wilson JE, McManus BM. Giant cell arteritis of the legs. Clinical isolation of severe disease with gangrene and amputations. Am J Med. 1986;81:727-733.
40. Halpin DP, Moran KT, Jewell ER. Arm ischemia secondary to giant cell arteritis. Ann Vasc Surg. 1988;2:381-384.
41. Hamilton CR Jr, Shelley WM, Tumulty PA. Giant cell arteritis: including temporal arteritis and polymyalgia rheumatica. Medicine (Baltimore). 1971;50:1-27.
42. Hamrin B. Stenosing arteritis of the subclavian axillary arteries (polymyalgia rheumatica sine arteritica). Acta Chir Scand. 1976;142(suppl 465):80-83.
43. Hamrin B, Jonsson N, Landberg T. Involvement of large vessels in polymyalgia rheumatica. Lancet. 1965;1:1193-1196.
44. Hatzis GS, Aroni KG, Kelekis DA, Boki KA. Giant cell arteritis presenting as pulseless disease of the upper extremities. Clin Rheumatol. 1996;15:88-90.
45. Healey LA, Wilske KR. Presentation of occult giant cell arteritis. Arthritis Rheum. 1980;23:641-643.
46. Helfgott SM, Bauer MR. Pedal gangrene caused by giant cell arteritis. Arthritis Rheum. 1987;30:1078-1079.
47. Hellmann DB. Low-dose aspirin in the treatment of giant cell arteritis. Arthritis Rheum. 2004;50:1026-1027.
48. Houdent C, Deshayes P, Husson A, Tayot J, Wolf LM. Arterite giganto-cellulaire des gros troncs. Lyon Med. 1979;241:855-861.
49. HunDer GG, Bloch DA, Michel BA, Stevens MB, Arend WP, Calabrese LH, Edworthy SM, Fauci AS, Leavitt RY, Lie JT, et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum. 1990;33:1222-1228.
50. HunDer GG, Sheps SG. Intermittent claudication and polymyalgia rheumatica. Arch Intern Med. 1967;119:638-643.
51. HunDer GG, Sheps SG, Allen GL, Joyce JW. Daily and alternate-day corticosteroid regimens in treatment of giant cell arteritis. Arch Intern Med. 1975;82:613-618.
52. Jennings GH, Camb MB. Arteritis of the temporal vessels. Lancet. 1938;1:424-428.
53. Jouquan J, Mottier D, Cleuziou A, Pennec Y, Baccino E, Bergeret G, Garo B. Accidents vasculaires cerebraux precoces au cours de maladies de Horton traitees: responsabilite du traitement corticoide? Ann Med Interne. 1984;135:526-529.
54. Karassa FB, Matsagas MI, Schmidt WA, Ionnidis JPA. Meta-analysis: test performance of ultrasonography for giant-cell arteritis. Ann Intern Med. 2005;142:359-369.
55. Kermani TA, Matteson EL, HunDer GG, Warrington KJ. Symptomatic lower extremity vasculitis in giant cell arteritis: a case series. J Rheumatol. 2009;36:2277-2283.
56. Klein RG, HunDer GG, Stanson AW, Sheps SG. Large artery involvement in giant cell (temporal) arteritis. Ann Intern Med. 1975;83:806-812.
57. Kolossvary E, Kollar A, Pinet H, Erenyi E, Kisery I, Peter H, Farkas K, Mogan L, Farsang C, Kiss I. Bilateral axillobrachial and external carotid artery manifestation of giant cell arteritis: important role of color duplex ultrasonography in the diagnosis. Int Angiol. 2005;24:202-205.
58. Le Hello C, Levesque H, Jeanton M, Cailleux N, Galateau F, Peillon C, Veyssier P, Watelet J, Letellier P, Courtois H, Maiza D. Lower limb giant cell arteritis and temporal arteritis: follow up of 8 cases. J Rheumatol. 2001;28:1407-1412.
59. Lee MS, Smith SD, Galor A, Hoffman GS. Antiplatelet and anticoagulant therapy in patients with giant cell arteritis. Arthritis Rheum. 2006;54:3306-3309.
60. Lie JT. Aortic and extracranial large vessel giant cell arteritis: a review of 72 cases with histopathologic documentation. Semin Arthritis Rheum. 1995;24:422-431.
61. Liozon F, Jauberteau-Marchan MO, Boutros-Toni F, Barrier JH, Dupond JL, Roblot P, Liozon E, Delaire L, Vidal E. Anticorps anti-cardiolipine et maladie de Horton. Ann Med Interne. 1995;146:541-573.
62. Liozon F, Vidal E, Dany F, Bordessoule D, Adilouze JL, Drouet M. Arterial stenoses of the arms in Hortons temporal arteritis. A propos of 3 cases. A review of the literature. Ann Med Interne. 1986;137:307-312.
63. Long A, Bruneval P, Laurian C, Cormier JM, Camilleri JP, Fiessinger JN. Extratemporal Hortons disease: diagnosis using subclavian biopsy. 4 cases. Arch Mal Coeur Vaiss. 1989;82: 1727-1731.
64. Maksimowicz-McKinnon K, Clark TM, Hoffman GS. Takayasu arteritis and giant cell arteritis. A spectrum within the same disease? Medicine (Baltimore). 2009;88:221-226.
65. Marie I, Proux A, Duhaut P, Primard E, Lahaxe L, Girszyn N, Louvel JP, Levesque H. Long-term follow-up of aortic involvement in giant cell arteritis: a series of 48 patients. Medicine (Baltimore). 2009;88:182-192.
66. Mickley V, Kogel H, Vogel U. Bilateral brachial claudication as the initial manifestation of giant cell arteritisVcase report and review of literature. Vasa. 1992;24:415-421.
67. Missen GAK. Arteritis of the arms. Br Med J. 1981;282:2055.
68. Monte R, Gonzalez-Gay MA, Garcia-Porrua C, Lopez-Alvarez MJ, Pulpeiro JR. Successful response to angioplasty in a patient with upper limb ischaemia secondary to giant cell arteritis. Br J Rheumatol. 1998;37:344.
69. Nesher G, Berkun Y, Mates M, Baras M, Rubinow A, Sonnenblick M. Low-dose aspirin and prevention of cranial ischemic complications in giant cell arteritis. Arthritis Rheum. 2004;50:1332-1137.
70. Ninet JP, Bachet P, Dumontet CM, Du Colombier PB, Stewart MD, Pasquier JH. Subclavian and axillary involvement in temporal arteritis and polymyalgia rheumatica. Am J Med. 1990;88:13-20.
71. Nordborg E, Nordborg C. Giant cell arteritis: epidemiological clues to its pathogenesis and an update on its treatment. Rheumatology (Oxford). 2003;42:413-421.
72. Nuenninghoff DM, HunDer GG, Christianson TJ, McClelland RL, Matteson EL. Incidence and predictors of large-artery complication (aortic aneurysm, aortic dissection, and/or large-artery stenosis) in patients with giant cell arteritis: a population-based study over 50 years. Arthritis Rheum. 2003;48:3522-3531.
73. Nuenninghoff DM, HunDer GG, Christianson TJ, McClelland RL, Matteson EL. Mortality of large-artery complication (aortic aneurysm, aortic dissection, and/or large-artery stenosis) in patients with giant cell arteritis: a population-based study over 50 years. Arthritis Rheum. 2003;48:3532-3537.
74. Obrien PK, Pudden AJ. Peripheral arterial insufficiency due to giant cell arteritis. Can J Surg. 1978;21:441-442.
75. Ostberg G. An arteritis with special reference to polymyalgia arteritica. Acta Pathol Microbiol Scand. 1973;237(suppl):1-59.
76. Ostberg G. Temporal arteritis in a large necropsy series. Ann Rheum Dis. 1971;30:224-235.
77. Petrie JP, Sheppeard H. Giant cell arteritis diagnosed following arm claudication. Aust N Z J Med. 1984;14:275-276.
78. Pipitone N, Versari A, Salvarani C. Role of imaging studies in the diagnosis and follow-up of large-vessel vasculitis: an update. Rheumatology (Oxford). 2008;47:403-408.
79. Reichelt HG, Schmidtchen M. Bilateral symmetrical obliteration syndrome of the subclavian-brachial system in the elDerly female. Rontgenblatter. 1990;43:332-334.
80. Rischmueller M, Davies RP, Smith MD. Three year follow-up of a caseof giant cell arteritis presenting with a chronic cough and upper limb ischaemic symptoms. Br J Rheumatol. 1996;35:800-802.
81. Rivers SP, Baur GM, Inahara T, Porter JM. Arm ischemia secondary to giant cell arteritis. Am J Surg. 1982;143:554-558.
82. Salvarani C, Cantini F, Boiardi L, HunDer GG. Polymyalgia rheumatica and giant-cell arteritis. N Engl J Med. 2002;347:261-271.
83. Salvarani C, Della Bella C, Cimino L, Macchioni P, Formisano D, Bajocchi G, Pipitone N, Catanoso MG, Restuccia G, Ghinoi A, Boiardi L. Risk factors for severe cranial ischaemic events in an Italian population-based cohort of patients with giant cell arteritis. Rheumatology (Oxford). 2009;48:250-253.
84. Salvarani C, Gabriel SE, Ofallon WM, HunDer GG. The incidence of giant cell arteritis in Olmsted country, Minnesota: apparent fluctuations in a cyclic pattern. Ann Intern Med. 1995;123:192-194.
85. Samanta A, Sheldon P. Polymyalgia rheumatica with bilateral subclavian artery occlusion. Br J Rheumatol. 1987;26:469-470.
86. Sato M, Takeda A, Hagiwara S, Mochizuki M, Minato N, Saito K, Kano S. Giant cell arteritis and polymyalgia rheumatica presenting as subclavian artery obstruction. Ryumachi. 1993;33:330-334.
87. Schmidt WA, Blockmans D. Use of ultrasonography and positron emission tomography in the diagnosis and assessment of large-vessel vasculitis. Curr Opin Rheumatol. 2005;17:9-15.
88. Schmidt WA, Kraft HE, Borowski A, Gromnica-Ihle EJ. Color duplex ultrasonography in large-vessel giant cell arteritis. Scand J Rheumatol. 1999;28:374-376.
89. Schmidt WA, Kraft HE, Vorpahl K, Volker L, Gromnica-Ihle EJ. Color duplex ultrasonography in the diagnosis of temporal arteritis. N Engl J Med. 1997;337:1336-1342.
90. Schmidt WA, Moll A, Seifert A, Schicke B, Gromnica-Ihle E, Krause A. Prognosis of large-vessel giant cell arteritis. Rheumatology (Oxford). 2008;47:1406-1408.
91. Schmidt WA, Natusch A, Moller DE, Vorpahl K, Gromnica-Ihle E. Involvement of peripheral arteries in giant cell arteritis: a color Doppler sonography study. Clin Exp Rheumatol. 2002;20:309-318.
92. Schmidt WA, Seifert A, Gromnica-Ihle E, Krause A, Natusch A. Ultrasound of proximal upper extremity arteries to increase the diagnostic yield in large-vessel giant cell arteritis. Rheumatology (Oxford). 2008;47:96-101.
93. Series C, Cheradame I, Baste JC, Midy D. Maladie de Horton revelee par une atteinte des membres inferieurs. Rev Med Interne. 1993;14:317-319.
94. Shibata T, Shibata T, Ozaki S, Ichikawa Y, Itoh G. A case of polymyalgia rheumatica where a complication of large-vessel vasculitis was diagnosed with FDG-PET. Nihon Rinsho Meleki Gakkai Kaishi. 2009;32:129-134.
95. Skopinski S, Constans J, Cherifi H, Midy D, Jarnier P, Le Metayer P, Baste JC, Bakhach S, Conri C. Arteriopathie inflammatoire des membres superieurs au cours de la maladie de Horton. A propos de six cas. J Mal Vasc. 1999;24:45-48.
96. Soury P, Brisset D, Saliou C, Sraieb T, Angel F, Fiessinger JN, Laurian C. Lesions arterielles des membres superieurs dans la maladie de Horton. Revascularisation chirurgicale par pontage carotido-humeral bilateral. Presse Med. 1997;26:1478-1480.
97. Stanley D, HenDerson D, Harris S. Giant cell arteritis associated with pericarditis and large vessel disease. Aust N Z J Med. 1991;21:353-355.
98. Stanson AW. Imaging findings in extracranial (giant cell) temporal arteritis. Clin Exp Rheumatol. 2000;18(suppl 20):S43-S48.
99. Stanson AW, Klein RG, HunDer GG. Extracranial angiographic findings in giant cell (temporal) arteritis. AJR Am J Roentgenol. 1976;127:957-963.
100. Stautner-Bruckmann C, Haschka C, Baumann G, Bogner J, Spengel FA. Rienzenzellarteritis mit isoliertem befall Der femoralarterien. Dtsch Med Wochenschr. 1992;117:974-977.
101. Svendler CA, SoDerlundh S. Angiographic diagnosis in polymyalgia arteritica. Acta Radiol Diagn (Stock). 1977;18:333-338.
102. Swinson DR, Goodwill CJ, Talbot IC. Giant cell arteritis presenting as subclavian artery occlusion. A report of two cases. Postgrad Med J. 1976;52:525-529.
103. Taieb C, Curet P, Bousquet JC, Grellet J. Hortons disease with bilateral axillohumeral localization. Arteriographic aspects: 2 cases. J Radiol. 1984;65:573-577.
104. Tarnoff JF, Pearlman E, Balkoura MH, Venkataraman M. Bilateral superficial femoral giant cell arteritis. J Cardiovasc Surg. 1990;31:375-379.
105. Tato F, Hoffmann U. Clinical presentation and vascular imaging in giant cell arteritis of the femoropopliteal and tibioperoneal arteries. Analysis of four cases. J Vasc Surg. 2006;44:176-182.
106. Tazi Z, Cacoub P, Cheysson D, Godeau B, Piette JC. Maladie de Horton demasquee par une arteriopathie inflammatoire specifique des membres inferieurs. Rev Med Interne. 1997;18: 638-641.
107. Thompson JR, Simmons CR, Smith LL. Polymyalgia arteritica with bilateral subclavian artery occlusive disease. A case report. Radiology. 1971;101:595-596.
108. Viallard JF, Fach J, Neau D, Monlun E, de Mascarel A, Longy-Boursier M, Lebras M. Giant cell arteritis of the lower limbs in rhizomelic pseudopolyarthritis. Ann Med Interne. 1996;147: 225-227.
109. Vinckier L, Hatron PY, Gadenne C, Catteau MH, Gosset D, DevulDer B. Sensibilite et specificite du Doppler temporal dans la maladie de Horton. J Mal Vasc. 1989;14(suppl C):104-108.
110. Vinckier L, Hatron PY, Gadenne C, Catteau MH, Gosset D, DevulDer B. Interet du Doppler arteriel dans la maladie de Horton: etude prospective de 59 observations. J Mal Vasc. 1989;14(suppl C): 116-122.
111. Walz-Leblanc BA, Ameli FM, Keystone EC. Giant cell arteritis presenting as limb claudication. Report and review of the literature. J Rheumatol. 1991;18:470-472.
112. Watts RA, Coppen M, Bhalla AK, BinDer AI. Giant cell arteritis presenting as limb claudication. J R Soc Med. 1989;82:51-52.
113. Weyand CM, Bartley GB. Giant cell arteritis: new concepts in pathogenesis and implications for management. Am J Ophthalmol. 1997;123:392-395.
114. Weyand CM, Goronzy JJ. Arterial wall injury in giant cell arteritis. Arthritis Rheum. 1999;42:844-853.
115. Weyand CM, Goronzy JJ. Giant-cell arteritis and polymyalgia rheumatica. Ann Intern Med. 2003;139:505-515.
116. Yun M, Yeh D, Araujo LI, Jang S, Newberg A, Alavi A. F-18 FDG uptake in the large arteries: a new observation. Clin Nucl Med. 2001;26:314-319.
117. Zaidi FH, King ER. Atypical giant cell arteritis resulting in arm amputation. Am R Coll Surg Engl. 2005;85:260-262.